NIH-funded research NIH-funded research

DYRK1A and facial development: finding the right balance to prevent birth defects

Official title: Dyrk1a, a Goldilocks protein in embryonic development

Funded at Virginia Commonwealth University · NIH-11576157 · Data updated 2026-11-12

This project explores how changing levels of the DYRK1A protein affect face formation in embryos and in cells from people with Down syndrome.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVirginia Commonwealth University
NIH-funded
Lab location1 site (Richmond, United States)
Project startAugust 7, 2026
Project endAugust 6, 2028
Funding year2026
Award (this year)$378,520
NIH project number1R56DE034980-01A1
Project IDNIH-11576157 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants are families or individuals with Down syndrome or DYRK1A-related syndromes, and researchers working with patient-derived cells.

Less likely to help

Patients without DYRK1A-related craniofacial involvement may not directly benefit from this research.

What this research studies

DYRK1A dosage appears to influence facial development and cell processes like division and survival. The researchers will use a developmental frog model and human cells to see how excess or deficient DYRK1A changes the developing face and contributes to birth defects. They will test whether reducing senescence in cells or correcting DYRK1A levels can lessen craniofacial abnormalities. The study combines animal experiments with human-derived cells to understand mechanisms and potential interventions.

Why it matters

Potential benefit: If successful, findings could lead to strategies to reduce birth defects and improve developmental outcomes for individuals affected by DYRK1A-related conditions and Down syndrome.

How similar studies have gone: Previous work suggests DYRK1A dosage affects development, but direct intervention strategies are still being explored.

Where this research is happening

  • Virginia Commonwealth University
    Richmond, United States
    Active

Researchers

  • Principal investigator: Dickinson, Amanda Jane — Virginia Commonwealth University
  • Study coordinator: Dickinson, Amanda Jane

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.